The National Asthma Council Logo

 

 

Leading the attack against asthma

Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 
Asthma information Papers
 
Asthma Management Handbook Asthma Action Plans Spirometry Resources  Other Resources Information Papers Special Topics Professional Development  

Asthma Information Papers

Allergic rhinitis and the patient with asthma
Treat allergic rhinitis to manage asthma
Diagnosis
Patterns of allergic rhinitis
Management I
Management II
Management III
Management IV
Review
Levels of evidences
References
Content created Sep 2006
Content updated Sep 2006


Get Acrobat Viewer

 

Allergic rhinitis and the patient with Asthma

A guide for health professionals

NextBack

Contents

Treat allergic rhinitis to manage asthma

Patterns of allergic rhinitis

Diagnosis

Management I

 - Allergen avoidance
 - Consider nasal irrigation

Management II

 - Pharmacological treatment
 - Other agents and adjuncts

Management III

 - Pregnant women
 - Young children
 - Patients with allergic rhinitis and asthma

Management IV

 - Immunomodulatory therapy

Review

Levels of evidences

References

Allergic rhinitis and the patient with Asthma

Summary of evidence

  • Effective treatment of allergic rhinitis improves asthma control and lung function.<Level II>

  • Measures that have consistently been reported effective in reducing mite exposure include hot (>55 degrees C) washing of all bedding and the use of mite-proof cases for mattresses and pillows.<Level II>

  • Intranasal corticosteroids are more effective than antihistamines in controlling symptoms of allergic rhinitis as well as non-allergic rhinitis.<Level I>

  • Long-term use of newer intranasal corticosteroids does not appear to affect the hypothalamic–pituitary–adrenal (HPA) axis or cause mucosal atrophy.<Level II>

  • Specific allergen immunotherapy is effective in the management of rhinitis and asthma and can achieve a durable remission of allergic symptoms. <Level I>

  • Specific allergen immunotherapy may reduce the risk of childhood rhinitis progressing to asthma.<Level II>

Note

This information paper is intended to provide information on the clinical interrelationship between asthma and allergic rhinitis for GPs, asthma educators, practice nurses and pharmacists. For more information on the diagnosis and management of allergic rhinitis in primary care, see: Australasian Society of Clinical Immunology and Allergy. Asthma and Allergy. Australian Government Department of Health and Ageing 2005 (available at: www.nationalasthma.org.au).

Acknowledgements

This brochure has been proudly sponsored by

Schering-Plough

 

National Asthma Council Australia
ABN 61 058 044 634
1 Palmerston Crescent,
South Melbourne VIC 3205
Tel: 03 8699 0476
Fax: 03 8699 0400
Email: nac@nationalasthma.org.au
www.nationalasthma.org.au September 2006

Disclaimer

Although all care has been taken, this information paper is a general guide only which is not intended to be a substitute for individual medical advice/treatment. The National Asthma Council expressly disclaims all responsibility (including for negligence) for any loss, damage or personal injury resulting from reliance on the information contained.

Top of page